Literature DB >> 21607135

Non-random tissue distribution of human naïve umbilical cord matrix stem cells.

Dharmendra Kumar Maurya1, Chiyo Doi, Marla Pyle, Raja Shekar Rachakatla, Duane Davis, Masaaki Tamura, Deryl Troyer.   

Abstract

AIM: To determine the tissue and temporal distribution of human umbilical cord matrix stem (hUCMS) cells in severe combined immunodeficiency (SCID) mice.
METHODS: For studying the localization of hUCMS cells, tritiated thymidine-labeled hUCMS cells were injected in SCID mice and tissue distribution was quantitatively determined using a liquid scintillation counter at days 1, 3, 7 and 14. Furthermore, an immunofluorescence detection technique was employed in which anti-human mitochondrial antibody was used to identify hUCMS cells in mouse tissues. In order to visualize the distribution of transplanted hUCMS cells in H&E stained tissue sections, India Black ink 4415 was used to label the hUCMS cells.
RESULTS: When tritiated thymidine-labeled hUCMS cells were injected systemically (iv) in female SCID mice, the lung was the major site of accumulation at 24 h after transplantation. With time, the cells migrated to other tissues, and on day three, the spleen, stomach, and small and large intestines were the major accumulation sites. On day seven, a relatively large amount of radioactivity was detected in the adrenal gland, uterus, spleen, lung, and digestive tract. In addition, labeled cells had crossed the blood brain barrier by day 1.
CONCLUSION: These results indicate that peripherally injected hUCMS cells distribute quantitatively in a tissue-specific manner throughout the body.

Entities:  

Keywords:  Human umbilical cord matrix stem cells; Immunohistochemistry; India black ink loaded cells; Radio-labeled transplanted cells; Tissue distribution

Year:  2011        PMID: 21607135      PMCID: PMC3097938          DOI: 10.4252/wjsc.v3.i4.34

Source DB:  PubMed          Journal:  World J Stem Cells        ISSN: 1948-0210            Impact factor:   5.326


  30 in total

Review 1.  The hallmarks of cancer.

Authors:  D Hanahan; R A Weinberg
Journal:  Cell       Date:  2000-01-07       Impact factor: 41.582

2.  A role for bone marrow-derived cells in the vasculature of noninjured CNS.

Authors:  Francesco Galimi; Robert G Summers; Henriette van Praag; Inder M Verma; Fred H Gage
Journal:  Blood       Date:  2004-11-30       Impact factor: 22.113

3.  Fetal microchimerism in the maternal mouse brain: a novel population of fetal progenitor or stem cells able to cross the blood-brain barrier?

Authors:  Xiao-Wei Tan; Hong Liao; Li Sun; Masaru Okabe; Zhi-Cheng Xiao; Gavin S Dawe
Journal:  Stem Cells       Date:  2005-08-09       Impact factor: 6.277

4.  Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas.

Authors:  Akira Nakamizo; Frank Marini; Toshiyuki Amano; Asadullah Khan; Matus Studeny; Joy Gumin; Julianne Chen; Stephen Hentschel; Giacomo Vecil; Jennifer Dembinski; Michael Andreeff; Frederick F Lang
Journal:  Cancer Res       Date:  2005-04-15       Impact factor: 12.701

5.  Induction of ductal and stromal hyperplasia by basic fibroblast growth factor produced by human pancreatic carcinoma.

Authors:  H Kuniyasu; J L Abbruzzese; K R Cleary; I J Fidler
Journal:  Int J Oncol       Date:  2001-10       Impact factor: 5.650

6.  Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents.

Authors:  Matus Studeny; Frank C Marini; Jennifer L Dembinski; Claudia Zompetta; Maria Cabreira-Hansen; Benjamin Nebiyou Bekele; Richard E Champlin; Michael Andreeff
Journal:  J Natl Cancer Inst       Date:  2004-11-03       Impact factor: 13.506

7.  Highly proliferative intratumoral fibroblasts and a high proliferative microvessel index are significant predictors of tumor metastasis in T3 ulcerative-type colorectal cancer.

Authors:  T Hasebe; S Sasaki; M Sugitoh; M Ono; N Saitoh; A Ochiai
Journal:  Hum Pathol       Date:  2001-04       Impact factor: 3.466

8.  Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors.

Authors:  Matus Studeny; Frank C Marini; Richard E Champlin; Claudia Zompetta; Isaiah J Fidler; Michael Andreeff
Journal:  Cancer Res       Date:  2002-07-01       Impact factor: 12.701

9.  Variations in uterine innervation during the estrous cycle in rat.

Authors:  E V Zoubina; Q Fan; P G Smith
Journal:  J Comp Neurol       Date:  1998-08-10       Impact factor: 3.215

10.  Matrix cells from Wharton's jelly form neurons and glia.

Authors:  Kathy E Mitchell; Mark L Weiss; Brianna M Mitchell; Phillip Martin; Duane Davis; Lois Morales; Bryan Helwig; Mark Beerenstrauch; Khalil Abou-Easa; Tammi Hildreth; Deryl Troyer; Satish Medicetty
Journal:  Stem Cells       Date:  2003       Impact factor: 6.277

View more
  1 in total

1.  Neurotherapeutic effect of cord blood derived CD45+ hematopoietic cells in mice after traumatic brain injury.

Authors:  Hadar Arien-Zakay; Galit Gincberg; Arnon Nagler; Gadi Cohen; Sigal Liraz-Zaltsman; Victoria Trembovler; Alexander G Alexandrovich; Ilan Matok; Hanan Galski; Uriel Elchalal; Peter I Lelkes; Philip Lazarovici; Esther Shohami
Journal:  J Neurotrauma       Date:  2014-07-14       Impact factor: 5.269

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.